company
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-05-13Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Class II recall: TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag,…
Frequently asked questions
- How many FDA warning letters has Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles received?
- Argus HQ has not recorded an FDA warning letter for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles in our current dataset.
- What FDA recalls has Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles issued?
- Argus HQ has recorded 1 FDA recall tied to Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles.
- Is Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.